Recent Updates
Recently added Catalysts
VIR Positive Sentiment Score: 60/100

Vir Biotechnology to Participate in the 44th Annual Goldman Sachs Global Healthcare Conference

Monday, June 5, 2023 1 min read
Key Takeaway: Vir Biotechnology, Inc. will have its CEO, Marianne De Backer, participate in a fireside chat at the 44th Annual Goldman Sachs Global Healthcare Conference. The event is scheduled for June 12, and interested parties can access a live webcast of the presentation. This participation highlights the company's commitment to addressing serious infectious diseases through advanced immunology technologies.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a prominent healthcare conference showcases industry engagement.
  • Opportunity for the CEO to present company advancements to a broader audience.
  • Live webcast provides accessibility for investors and stakeholders.

Full Press Release Details

SAN FRANCISCO, June 05, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, is scheduled to participate in a fireside chat at the 44th Annual Goldman Sachs Global Healthcare Conference on Monday, June 12, at 10:40 a.m. PT / 1:40 p.m. ET.
A live webcast of the presentation can be accessed under Events & Presentations in the Investors section of the Vir website at www.vir.bio and will be archived there for 30 days.
About Vir Biotechnology
Vir Biotechnology is a commercial-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current development pipeline consists of product candidates targeting COVID-19, hepatitis B and D viruses, influenza A and human immunodeficiency virus. Vir routinely posts information that may be important to investors on its website.

Tags

Goldman Sachs Conference

Frequently Asked Questions

When is the Goldman Sachs Global Healthcare Conference?

The conference is on June 12, 2023, at 10:40 a.m. PT.

Who will represent Vir Biotechnology at the conference?

Marianne De Backer, CEO of Vir Biotechnology, will participate.

Where can I watch the webcast of the presentation?

The live webcast will be available on the Vir website under Events & Presentations.

How long will the webcast be archived?

The webcast will be archived for 30 days on Vir's website.

What is Vir Biotechnology focused on?

Vir Biotechnology aims to treat and prevent serious infectious diseases.

Tags: VIR Viatris Investor Conferences Healthcare Vir Biotechnology Goldman Sachs healthcare conference Marianne De Backer immunology
Last updated: Jun 5, 2023